Technology Offerings (invention with patent)
The First Class of Inhibitors for YEATS Domain as Potential Therapeutic Agents for Acute Leukemia
Inhibitors to block ENL–chromatin interaction, preventing downstream oncogene transcription
Therapeutic Chemicals
Novel Analogues of Teixobactin and the Synthetic Method
Total chemical synthesis of teixobactin and its analogues, offering novel, improved antibacterial compounds
Therapeutic Chemicals
OPTIClear: A Novel Tissue Clearing Agent for the Next Generation Histology
the optical properties of tissue while leaving the structural components unchanged, minimizing tissue damage
Research Tools and Methods
A New Class of Metallo-β-lactamases inhibitors Against Antibacterial Resistance
Bismuth compounds can be administered in combination with β-lactam antibiotics to treat MBL-producing bacterial infection
Therapeutic Chemicals
Palladium (II) Complexes in Anti-cancer
Chemotherapy complexes with high stability in vitro and against physiological thiols
Therapeutic Chemicals
Platinum Complexes for Anti-cancer Treatment
Platinum complexes with high cell uptake efficiency, high nuclear DNA binding efficacy and higher toxicity than cisplatin and oxaliplatin
Therapeutic Chemicals
Immuno-Oncolytic Modified Vaccinia Tian Tan Virus and Methods of Treating Cancer
Methods to induce protective antitumor T cell responses, which are normally suppressed or even absent under the tumor environment
Therapeutic Biologics
Neutrophil Elastase (NE) and Proteinase 3 (PR3) as Diagnostic Biomarkers for Autoimmune Diabetes
Antibodies and methods for early diagnosis of Type 1 diabetes by measuring elevated activity of NE and PR3
Diagnostics